Is PCVX or PDSB more undervalued in 2026?

CirclFi compares Vaxcyte, Inc. (PCVX) and PDS Biotechnology Corporation (PDSB) using 13 institutional-grade valuation models. PCVX has a Quality of Company score of 5.1/10 while PDSB scores 4.0/10.

Which is a better buy — PCVX or PDSB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PCVX and PDSB valuations compare?

PCVX at $51.06 and PDSB at $1.07 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PCVX vs PDSB Valuation Comparison 2026 — Intrinsic Value Analysis

PCVX

Biotechnology

Vaxcyte, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$51.06

Last close

Models

10/13

Active

PDSB

Biotechnology

PDS Biotechnology Corporation

Quality

4.0

out of 10

Value Trap

LOW

Price

$1.07

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	PCVX Fair Value	PCVX Upside	PDSB Fair Value	PDSB Upside
Bayesian DCF	Intrinsic	$16.06	-68.6%	$0.50	-53.6%
Earnings Power Value	Intrinsic	$27.17	-54.3%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$15.19	-70.3%	$0.63	-40.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PCVX vs PDSB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PCVX vs PDSB — Which Stock Is More Undervalued?

PCVX scores higher with a 5.1/10 quality rating vs PDSB's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Vaxcyte, Inc. (PCVX) and PDS Biotechnology Corporation (PDSB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PCVX currently trades at $51.06 with a QOC of 5.1/10, while PDSB trades at $1.07 with a QOC of 4.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).